ALTANINE Trademark

Trademark Overview


On Thursday, July 11, 2024, a trademark application was filed for ALTANINE with the United States Patent and Trademark Office. The USPTO has given the ALTANINE trademark a serial number of 98644252. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 3, 2025. This trademark is owned by Altanine, Inc.. The ALTANINE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for treatment of illnesses, namely, diabetes, consisting of metformin; pharmaceutical preparations for treatment of illnesses, namely, migraines, consisting of Sumatriptan; pharmaceutical preparations for treatment of illnesses, namely, diabetes, weight control, heart and blood vessel disease, consisting of semaglutide; pharmaceutical preparations for treatment of illnesses, namely, sexual wellness, and pulmonary hypertension, consisting of Sildenafil; Pharmaceutical preparations for treatment of diabetes, weight control, sexual wellness, and neurocare

Pharmaceutical drug research and development; drug discovery services; pharmaceutical drug research and development in field of diabetes, weight control, sexual wellness, and neurocare
altanine

General Information


Serial Number98644252
Word MarkALTANINE
Filing DateThursday, July 11, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, June 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 3, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for treatment of illnesses, namely, diabetes, consisting of metformin; pharmaceutical preparations for treatment of illnesses, namely, migraines, consisting of Sumatriptan; pharmaceutical preparations for treatment of illnesses, namely, diabetes, weight control, heart and blood vessel disease, consisting of semaglutide; pharmaceutical preparations for treatment of illnesses, namely, sexual wellness, and pulmonary hypertension, consisting of Sildenafil; Pharmaceutical preparations for treatment of diabetes, weight control, sexual wellness, and neurocare
Goods and ServicesPharmaceutical drug research and development; drug discovery services; pharmaceutical drug research and development in field of diabetes, weight control, sexual wellness, and neurocare

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 11, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 11, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAltanine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90024

Party NameAltanine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90024

Trademark Events


Event DateEvent Description
Wednesday, January 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 27, 2025ASSIGNED TO EXAMINER
Monday, February 3, 2025NON-FINAL ACTION WRITTEN
Monday, February 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 11, 2024NEW APPLICATION ENTERED
Monday, February 3, 2025NON-FINAL ACTION E-MAILED
Tuesday, April 29, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 29, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 29, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 29, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 29, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 29, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 29, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 29, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 29, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 29, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 29, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, May 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 5, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 28, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 3, 2025PUBLISHED FOR OPPOSITION
Tuesday, June 3, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, May 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED